HELP US CHANGE LIVES

Your donation has the power to transform lives. Whether it's a small or large contribution, your generosity can make a difference in the lives of patients now and in the future.

With your financial support, we can enroll patients in vital clinical trials that will not only benefit them but also pave the way for future patients worldwide.

By donating, you directly contribute to this research effort, sponsoring burn patients enrolled in the clinical trial. Your donation will help offset costs associated with:

Patient treatment expenses
Providing realSKIN® units for severe burn patients in the study
Testing analysis to ensure patient safety

Burn survivors often face a lifetime of challenges due to their injuries. Currently, there is no skin substitute or therapy that fully replicates the characteristics of healthy human skin needed for severe burn treatment.

Since 2016, we have been developing realSKIN®, a groundbreaking biotherapy for severe burns. Our ongoing 10-patient proof-of-concept clinical study brings us closer to market approval, offering hope to countless patients in need.

XenoTherapeutics is a not-for-profit research organization dedicated to restoring people's quality of life through innovative biotherapies.

Live cell biotherapies have revolutionized medical treatments, allowing the body to naturally replace damaged cells and tissues. This process is crucial for maintaining health and healing from illness, age, and injury.

We recognize the urgent needs of a growing global population. That's why we are committed to accelerating the testing, development, and commercialization of live biotherapeutic products to meet the true demand of the population.

Join us in changing lives. Learn more about XenoTherapeutics Foundation at https://www.xenotx.org/

Your support makes a meaningful impact.

Donate to Transform Lives with XenoTherapeutics

By XenoTherapeutics Inc

Donate to Transform Lives with XenoTherapeutics

Your Generosity Provides Healing Today and Ignites Hope for a Brighter Tomorrow.